BRIEF published on 09/21/2026 at 07:50, 1 month 12 days ago ALIKO Scientific Settles Dispute, US Subsidiary to Receive $2 Million Euronext Growth US Subsidiary Oncology Diagnostics Settlement ALIKO SCIENTIFIC
BRIEF published on 09/21/2026 at 07:50, 1 month 12 days ago ALIKO Scientific concludes a $2 million deal Dispute ALIKO SCIENTIFIC Transactional Agreement Oncological Diagnosis American Subsidiary
PRESS RELEASE published on 09/21/2026 at 07:45, 1 month 12 days ago Inside Information / Other news releases ALIKO Scientific settles dispute, US subsidiary to receive USD 2 million, related proceedings dismissed. ALIKO dedicated to oncology diagnostics US Subsidiary Oncology Diagnostics Settlement Dispute ALIKO SCIENTIFIC
BRIEF published on 09/15/2026 at 07:50, 1 month 18 days ago Aliko Scientific Expands in Brazil with Launch of Probantes ALIKO SCIENTIFIC FISH Probes Probantes Brazil Molecular Diagnostics Biodetecta Partnership
PRESS RELEASE published on 09/15/2026 at 07:45, 1 month 18 days ago Inside Information / Other news releases ALIKO Scientific launches Probantes in Brazil, establishing a new molecular diagnostic development and commercial platform for South America. Strategic agreement with Biodetecta enhances capabilities Brazil ALIKO SCIENTIFIC Probantes Molecular Diagnostic Biodetecta
BRIEF published on 09/07/2026 at 17:55, 1 month 25 days ago Aliko Scientific Launches U.S. Business Collaboration at ADLM 2026 U.S. Market ALIKO SCIENTIFIC ADLM 2026 Diagnostics Collaboration Partner International
PRESS RELEASE published on 09/07/2026 at 17:50, 1 month 25 days ago Inside Information / Other news releases Aliko Scientific partners with Partner International for U.S. business development at ADLM 2026, showing strong interest in oncology diagnostics technologies Oncology Diagnostics ALIKO SCIENTIFIC ADLM 2026 Partner International U.S. Business Development
BRIEF published on 08/24/2026 at 18:51, 2 months 9 days ago Aliko Scientific Updates Financial Position and Business Strategy Cash Flow Business Strategy Convertible Notes Financial Update Oncology Diagnostics
BRIEF published on 08/24/2026 at 18:47, 2 months 9 days ago Aliko Scientific: Financial Status and Outlook Convertible Bonds Financial Situation ALIKO SCIENTIFIC Outlook 2026 Oncological Diagnosis
PRESS RELEASE published on 08/24/2026 at 18:46, 2 months 9 days ago Inside Information: Other news releases ALIKO Scientific provides financial update post FY 2025 results publication, reaffirming business momentum. Details on auditors' reports, financial position, cash flow forecast, and convertible note financing Financial Update Convertible Note Financing Auditors' Reports ALIKO SCIENTIFIC FY 2025 Results
Published on 11/03/2026 at 15:30, 1 hour 48 minutes ago Murchison Minerals Announces $1 Million Non-Brokered Private Placement
Published on 11/03/2026 at 15:05, 2 hours 13 minutes ago ACCESS Newswire to Host Third Quarter Earnings Conference Call on November 10, 2026
Published on 11/03/2026 at 14:31, 2 hours 47 minutes ago First Breach Adds Inspection Equipment and Secures Strategic Supply Agreements to Support Ammunition Production
Published on 11/03/2026 at 14:00, 3 hours 18 minutes ago Global Education Communities Corp. Provides Corporate Update on Student Housing Portfolio and Development Projects
Published on 11/03/2026 at 13:48, 3 hours 30 minutes ago EonX Announces Strategic Technology Partnership with Metcash, Australia's Leading Wholesaler and Service Provider to Independent Business Operators
Published on 11/03/2026 at 16:30, 48 minutes ago Shudao Investment Group Shines at the Global Panda Partners Conference 2026
Published on 11/03/2026 at 16:05, 1 hour 12 minutes ago EQS-Adhoc: First Sensor AG: Change on the Supervisory Board
Published on 11/03/2026 at 16:00, 1 hour 18 minutes ago hep global and Engelhart sign one of Germany’s first full Hybrid PPAs
Published on 11/03/2026 at 15:37, 1 hour 40 minutes ago Alzchem Group AG focuses on continuity in sales: Martina Spitzer’s Management Board contract extended early through 2029
Published on 11/03/2026 at 07:00, 10 hours 18 minutes ago bioMérieux – Third-Quarter 2026 Business Review
Published on 11/02/2026 at 18:30, 22 hours 48 minutes ago Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 23 hours 1 minute ago Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 23 hours 18 minutes ago Covivio - Information on total number of voting rights and share capital
